4D Molecular Therapeutics (FDMT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $12.14, -5.67% vs the prior close of $12.87.
- Volume 794.53K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
FDMT slides 5.7% to $12.14, a 1-month low. Closed at $12.14, -5.67% vs the prior close of $12.87. Day range $12.00–$12.84, opened at $12.84.
FDMT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — FDMT slides 5.7% to $12.14, a 1-month low
- Closed at $12.14, -5.67% vs the prior close of $12.87. Day range $12.00–$12.84, opened at $12.84.
- Volume was 794.53K shares, 0.8x its 50-day average of 1.02M.
- Price is -12.8% vs its 50-day average ($13.91) and +14.0% vs its 200-day average ($10.65).
- 52-week range $6.96–$16.93; today's close sits at 52% of that range, 28.3% below the 52-week high.
Oct 15, 2026 — FDMT jumps 5.5% to $12.87
- Closed at $12.87, +5.49% vs the prior close of $12.20. Day range $12.04–$13.01, opened at $12.30.
- Volume was 787.60K shares, 0.8x its 50-day average of 1.02M.
- Price is -7.3% vs its 50-day average ($13.88) and +21.1% vs its 200-day average ($10.62).
- 52-week range $6.96–$16.93; today's close sits at 59% of that range, 24.0% below the 52-week high.
Oct 14, 2026 — FDMT dips 1.3% to $12.20, a 1-month low, 3 down days in a row
- Closed at $12.20, -1.29% vs the prior close of $12.36. Day range $11.99–$12.58, opened at $12.18.
- Volume was 633.00K shares, 0.6x its 50-day average of 1.02M.
- Price is -11.8% vs its 50-day average ($13.83) and +15.1% vs its 200-day average ($10.60).
- 52-week range $6.96–$16.93; today's close sits at 53% of that range, 27.9% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — FDMT slides 4.9% to $12.36, a 1-month low
- Closed at $12.36, -4.92% vs the prior close of $13.00. Day range $12.25–$12.91, opened at $12.91.
- Volume was 991.70K shares, 1.0x its 50-day average of 1.01M.
- Price is -10.4% vs its 50-day average ($13.79) and +16.9% vs its 200-day average ($10.58).
- 52-week range $6.96–$16.93; today's close sits at 54% of that range, 27.0% below the 52-week high.
Oct 12, 2026 — FDMT dips 2.5% to $13.00
- Closed at $13.00, -2.48% vs the prior close of $13.33. Day range $12.86–$13.47, opened at $13.30.
- Volume was 835.80K shares, 0.8x its 50-day average of 1.01M.
- Price is -5.4% vs its 50-day average ($13.75) and +23.2% vs its 200-day average ($10.55).
- 52-week range $6.96–$16.93; today's close sits at 61% of that range, 23.2% below the 52-week high.
Oct 9, 2026 — FDMT jumps 5.0% to $13.33, 3 up days in a row
- Closed at $13.33, +4.96% vs the prior close of $12.70. Day range $12.55–$13.85, opened at $12.70.
- Volume was 867.90K shares, 0.9x its 50-day average of 998.61K.
- Price is -2.6% vs its 50-day average ($13.69) and +26.6% vs its 200-day average ($10.53).
- 52-week range $6.96–$16.93; today's close sits at 64% of that range, 21.3% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — FDMT rises 0.9% to $12.70
- Closed at $12.70, +0.87% vs the prior close of $12.59. Day range $12.12–$12.73, opened at $12.42.
- Volume was 970.80K shares, 1.0x its 50-day average of 989.79K.
- Price is -6.8% vs its 50-day average ($13.62) and +20.9% vs its 200-day average ($10.51).
- 52-week range $6.96–$16.93; today's close sits at 58% of that range, 25.0% below the 52-week high.
Oct 7, 2026 — FDMT ends flat (+0.2%) to $12.59
- Closed at $12.59, +0.24% vs the prior close of $12.56. Day range $12.19–$12.92, opened at $12.36.
- Volume was 603.60K shares, 0.6x its 50-day average of 990.30K.
- Price is -7.2% vs its 50-day average ($13.56) and +20.1% vs its 200-day average ($10.49).
- 52-week range $6.96–$16.93; today's close sits at 56% of that range, 25.6% below the 52-week high.
Oct 6, 2026 — FDMT dips 2.8% to $12.56, a 1-month low, 6 down days in a row
- Closed at $12.56, -2.79% vs the prior close of $12.92. Day range $12.30–$13.02, opened at $12.64.
- Volume was 1.17M shares, 1.2x its 50-day average of 977.51K.
- Price is -7.0% vs its 50-day average ($13.51) and +20.0% vs its 200-day average ($10.47).
- 52-week range $6.96–$16.93; today's close sits at 56% of that range, 25.8% below the 52-week high.
- That makes 6 straight losses.
Oct 5, 2026 — FDMT slides 5.5% to $12.92, a 1-month low on 2.2x normal volume
- Closed at $12.92, -5.49% vs the prior close of $13.67. Day range $12.61–$13.86, opened at $13.86.
- Volume was 2.11M shares, 2.2x its 50-day average of 948.95K — unusually heavy trading.
- Price is -4.0% vs its 50-day average ($13.46) and +23.6% vs its 200-day average ($10.45).
- 52-week range $6.96–$16.93; today's close sits at 60% of that range, 23.7% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — FDMT dips 1.2% to $13.67, 4 down days in a row
- Closed at $13.67, -1.23% vs the prior close of $13.84. Day range $13.60–$14.14, opened at $14.12.
- Volume was 1.04M shares, 1.1x its 50-day average of 939.56K.
- Price is +2.0% vs its 50-day average ($13.41) and +30.9% vs its 200-day average ($10.44).
- 52-week range $6.96–$16.93; today's close sits at 67% of that range, 19.3% below the 52-week high.
- That makes 4 straight losses.
FDMT latest news & SEC filings
Every SEC filing by or about FDMT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kirn David sold 58,061 shares at $12.92 (≈$750.24K) on Oct 5, 2026; now holds 709,425
- Kirn David sold 272 shares at $13.61 (≈$3.70K) on Oct 5, 2026; now holds 709,153
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bizily Scott converted options/RSUs into 1,635 shares at $4.14 (≈$6.77K) on Sep 16, 2026; now holds 10,252
- Bizily Scott sold 1,635 shares at $13.65 (≈$22.32K) on Sep 16, 2026; now holds 8,617
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kirn David sold 58,333 shares at $13.90 (≈$811.00K) on Sep 14, 2026; now holds 767,486
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 14, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bizily Scott sold 584 shares at $14.00 (≈$8.18K) on Sep 1, 2026
- Bizily Scott sold 584 shares at $14.00 (≈$8.18K) on Sep 1, 2026
- Bizily Scott sold 584 shares at $14.00 (≈$8.18K) on Sep 1, 2026
- Bizily Scott sold 584 shares at $14.00 (≈$8.18K) on Sep 1, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $3.78M (prior year $15.00K) (+25106.7% vs Jun 30, 2025)
- Net income: -$72.94M (prior year -$54.66M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.04 (prior year -$0.98) (loss widened vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jun 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade FDMT
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 18, 2026, Jan 7, 2026. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.72% (largest 5.7%).
- Liquidity: about 1.07M shares (≈$12.94M) trade per day on average.
- 52-week position: $12.14 vs a range of $6.96–$16.93 (52% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Scott Bizily sold 1,635 shares on Sep 16, 2026.
- Latest filings: 8-K Sep 28, 2026; 10-Q Aug 13, 2026; 8-K Aug 13, 2026.
- Share count: 49.78M shares outstanding (Feb 23, 2024), +49.8% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
FDMT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 12.84 | 12.84 | 12.00 | 12.14 | 794.53K |
| Oct 15, 2026 | 12.30 | 13.01 | 12.04 | 12.87 | 787.60K |
| Oct 14, 2026 | 12.18 | 12.58 | 11.99 | 12.20 | 633.00K |
| Oct 13, 2026 | 12.91 | 12.91 | 12.25 | 12.36 | 991.70K |
| Oct 12, 2026 | 13.30 | 13.47 | 12.86 | 13.00 | 835.80K |
| Oct 9, 2026 | 12.70 | 13.85 | 12.55 | 13.33 | 867.90K |
| Oct 8, 2026 | 12.42 | 12.73 | 12.12 | 12.70 | 970.80K |
| Oct 7, 2026 | 12.36 | 12.92 | 12.19 | 12.59 | 603.60K |
| Oct 6, 2026 | 12.64 | 13.02 | 12.30 | 12.56 | 1.17M |
| Oct 5, 2026 | 13.86 | 13.86 | 12.61 | 12.92 | 2.11M |
| Oct 2, 2026 | 14.12 | 14.14 | 13.60 | 13.67 | 1.04M |
| Oct 1, 2026 | 14.23 | 14.58 | 13.80 | 13.84 | 655.50K |
| Sep 30, 2026 | 14.76 | 14.83 | 14.07 | 14.31 | 1.04M |
| Sep 29, 2026 | 14.70 | 14.97 | 13.94 | 14.49 | 1.38M |
| Sep 28, 2026 | 14.35 | 14.82 | 13.92 | 14.56 | 1.56M |
| Sep 25, 2026 | 14.77 | 14.82 | 14.03 | 14.47 | 1.02M |
| Sep 24, 2026 | 14.81 | 14.98 | 13.56 | 14.71 | 1.77M |
| Sep 23, 2026 | 15.97 | 15.97 | 14.68 | 15.00 | 1.47M |
| Sep 22, 2026 | 15.21 | 16.23 | 15.13 | 15.88 | 936.60K |
| Sep 21, 2026 | 15.57 | 15.70 | 14.68 | 15.24 | 699.10K |
About 4D Molecular Therapeutics
4D Molecular Therapeutics (FDMT) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in EMERYVILLE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1650648.
FDMT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jacob Chacko | Director | Jun 18, 2026 |
| Susannah Gray | Director | Jun 18, 2026 |
| David Kirn | See Remarks | Sep 16, 2026 |
| John F Milligan | Director | Jun 18, 2026 |
| Nancy Miller-Rich | Director | Jun 18, 2026 |
| Glenn Sblendorio | Director | Jun 18, 2026 |
| Charles Theuer | Director | Jun 18, 2026 |
| Shawn Tomasello | Director | Jun 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Scott Bizily | Chief Legal Officer | Sep 22, 2026 |
| Ashoo Gupta | VP, Finance and Controller | Mar 24, 2026 |
| Kristian Humer | Chief Financial Officer | Dec 11, 2025 |
| David Kirn | See Remarks | Sep 16, 2026 |
| Christopher Paul Simms | See Remarks | Mar 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 16, 2026 | Scott Bizily | Sale | 1,635 | $13.65 |
| Sep 16, 2026 | Scott Bizily | Sale | 1,635 | $13.65 |
| Sep 16, 2026 | Scott Bizily | Sale | 1,635 | $13.65 |
| Sep 16, 2026 | Scott Bizily | Sale | 1,635 | $13.65 |
| Sep 14, 2026 | David Kirn | Sale | 58,333 | $13.90 |
| Sep 14, 2026 | David Kirn | Sale | 58,333 | $13.90 |
| Sep 14, 2026 | David Kirn | Sale | 58,333 | $13.90 |
| Sep 14, 2026 | David Kirn | Sale | 58,333 | $13.90 |
| Sep 1, 2026 | Scott Bizily | Sale | 584 | $14.00 |
| Sep 1, 2026 | Scott Bizily | Sale | 584 | $14.00 |
| Sep 1, 2026 | Scott Bizily | Sale | 584 | $14.00 |
| Sep 1, 2026 | Scott Bizily | Sale | 584 | $14.00 |
| Aug 19, 2026 | David Kirn | Sale | 43,149 | $15.36 |
| Aug 19, 2026 | David Kirn | Sale | 25,927 | $16.42 |
| Aug 19, 2026 | David Kirn | Sale | 43,149 | $15.36 |
FDMT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $85.21M | $-140.11M | -2.42 | $-109.08M |
| Dec 31, 2024 | $37.00K | $-160.87M | -2.98 | $-134.59M |
| Dec 31, 2023 | $20.72M | $-100.84M | -2.58 | $-75.79M |
| Dec 31, 2022 | $3.13M | $-107.49M | -3.32 | $-86.69M |
| Dec 31, 2021 | $18.04M | $-71.32M | -2.57 | $-69.13M |
Latest balance sheet: total assets $492.62M, total liabilities $84.96M, cash $70.37M (as of Jun 30, 2026).
FDMT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $11.65 |
| May 7, 2026 | 8-K Item 2.02 (results) | $9.93 |
| Mar 18, 2026 | 8-K Item 2.02 (results) | $8.56 |
| Jan 7, 2026 | 8-K Item 2.02 (results) | $7.77 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $10.17 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $10.92 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $5.53 |
| May 8, 2025 | 8-K Item 2.02 (results) | $3.24 |
| Feb 28, 2025 | 8-K Item 2.02 (results) | $4.53 |
| Jan 10, 2025 | 8-K Item 2.02 (results) | $5.52 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $7.71 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on FDMT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.